Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université de Sherbrooke

$23,000.00

Hot-melt extrusion of polymers for pharmaceutical and biomedical applications

EF 2012-13

Résumé
The main objective of this program is to develop the full potential of melt-state extrusion/processing for the efficient fabrication of polymeric drug/biochemical controlled delivery systems for use in pharmaceutics or tissue-engineering applications. The main advantages of melt-state processing in the pharmaceutical and biomedical sector are the absence of residual solvents, the outstanding mixing and concentration uniformity, the ability to shape the material in 3D and the high productivity and the scalability to commercial production. Specific objectives of the program will be to: - Explore the potential of CO2-assisted processing as a means to process polymers carrying sensitive chemicals (e.g. drugs, peptides, proteins). - Develop the use immiscible hydrophobic/hydrophilic polymer pairs as carriers for controlled drug/chemical release - Develop porous polymer systems with controlled chemical release characteristics The developed knowledge will hopefully translate on the medium and long term into a greater array of products such as controlled release granules or tablets, transmucosal and transdermal systems, implants, bioresorbable polymeric scaffolds, etc. that can be safely and more efficiently mass-produced using melt-processing technologies.
Programme
Discovery Grants Program - Individual
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
298344-2010
Name nom
Huneault, Michel
Department département
Génie chimique et génie biotechnologique
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2010
Award amount
23000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
1808
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Rheology and processing
Research subject fr
Rhéologie et transformation
Partie
3
Nb partie
5
Application title
Hot-melt extrusion of polymers for pharmaceutical and biomedical applications
Keyword
NSERC
Application summary
The main objective of this program is to develop the full potential of melt-state extrusion/processing for the efficient fabrication of polymeric drug/biochemical controlled delivery systems for use in pharmaceutics or tissue-engineering applications. The main advantages of melt-state processing in the pharmaceutical and biomedical sector are the absence of residual solvents, the outstanding mixing and concentration uniformity, the ability to shape the material in 3D and the high productivity and the scalability to commercial production. Specific objectives of the program will be to: - Explore the potential of CO2-assisted processing as a means to process polymers carrying sensitive chemicals (e.g. drugs, peptides, proteins). - Develop the use immiscible hydrophobic/hydrophilic polymer pairs as carriers for controlled drug/chemical release - Develop porous polymer systems with controlled chemical release characteristics The developed knowledge will hopefully translate on the medium and long term into a greater array of products such as controlled release granules or tablets, transmucosal and transdermal systems, implants, bioresorbable polymeric scaffolds, etc. that can be safely and more efficiently mass-produced using melt-processing technologies.